Orhan Nalcioglu

Title(s)Professor Emeritus, Radiological Sciences
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-6001
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    COMBINED MR-DIFFUSE OPTICS FOR FUNCTIONAL IMAGING
    NIH R33CA101139Apr 16, 2004 - Mar 31, 2010
    Role: Principal Investigator
    COMBINED MR-DIFFUSE OPTICS FOR FUNCTIONAL IMAGING
    NIH R21CA101139Apr 16, 2004 - Mar 31, 2005
    Role: Principal Investigator
    PROGNOSIS OF METASTATIC DISEASE IN EARLY BREAST CANCER
    NIH R01CA090437Apr 1, 2001 - Mar 31, 2007
    Role: Principal Investigator
    AN MRI DETECTABLE NEOVASCULAR TARGETED ADENOVIRUS
    NIH R21CA083681Aug 1, 2000 - Jul 31, 2003
    Role: Principal Investigator
    CENTER FOR IN-VIVO MOLECULAR FUNCTIONAL ONCO-IMAGING
    NIH P20CA086182Apr 1, 2000 - Mar 31, 2004
    Role: Principal Investigator
    INVESTIGATION OF ANGIOGENIC FUNCTION IN CANCER BY MRI
    NIH R21CA086215Mar 8, 2000 - Feb 28, 2003
    Role: Principal Investigator
    INCOHERENT FLOW IMAGING BY NMR
    NIH R01CA045229Sep 1, 1987 - Jul 31, 1994
    Role: Principal Investigator
    DEVELOPMENT OF HIGHSPEED DYNAMIC NMR IMAGING TECHNIQUES
    NIH R01CA041307Jan 1, 1986 - Dec 31, 1988
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Feasibility study of a new RF coil design for prostate MRI. Phys Med Biol. 2014 Sep 07; 59(17):N163-9. Ha S, Roeck WW, Cho J, Nalcioglu O. PMID: 25138915.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. In vivo validation of quantitative frequency domain fluorescence tomography. J Biomed Opt. 2012 Dec; 17(12):126021. Lin Y, Ghijsen M, Nalcioglu O, Gulsen G. PMID: 23323291; PMCID: PMC3525318.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    3. Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences. Med Phys. 2011 Nov; 38(11):5961-8. Chang DH, Chen JH, Lin M, Bahri S, Yu HJ, Mehta RS, Nie K, Hsiang DJ, Nalcioglu O, Su MY. PMID: 22047360; PMCID: PMC3215688.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    4. Aquaporin-4-dependent edema clearance following status epilepticus. Epilepsy Res. 2012 Feb; 98(2-3):264-8. Lee DJ, Amini M, Hamamura MJ, Hsu MS, Seldin MM, Nalcioglu O, Binder DK. PMID: 21996149.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    5. Feasibility study of a unilateral RF array coil for MR-scintimammography. Phys Med Biol. 2011 Nov 07; 56(21):6809-22. Ha S, Hamamura MJ, Roeck WW, Hugg J, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 21971137; PMCID: PMC3517888.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Tumor characterization in small animals using magnetic resonance-guided dynamic contrast enhanced diffuse optical tomography. J Biomed Opt. 2011 Oct; 16(10):106015. Lin Y, Thayer D, Nalcioglu O, Gulsen G. PMID: 22029362; PMCID: PMC3221711.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    7. Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging. Radiology. 2011 Dec; 261(3):744-51. Chan S, Su MY, Lei FJ, Wu JP, Lin M, Nalcioglu O, Feig SA, Chen JH. PMID: 21878616; PMCID: PMC3219914.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    8. Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology. 2011 Dec; 261(3):735-43. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. PMID: 21878615; PMCID: PMC3219909.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    9. Spatial shrinkage/expansion patterns between breast density measured in two MRI scans evaluated by non-rigid registration. Phys Med Biol. 2011 Sep 21; 56(18):5865-75. Lin M, Chen JH, Mehta RS, Bahri S, Chan S, Nalcioglu O, Su MY. PMID: 21852724; PMCID: PMC3498815.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. Optimal analysis method for dynamic contrast-enhanced diffuse optical tomography. Int J Biomed Imaging. 2011; 2011:426503. Ghijsen M, Lin Y, Hsing M, Nalcioglu O, Gulsen G. PMID: 21811492; PMCID: PMC3147123.
      View in: PubMed   Mentions: 2  
    11. A photo-multiplier tube-based hybrid MRI and frequency domain fluorescence tomography system for small animal imaging. Phys Med Biol. 2011 Aug 07; 56(15):4731-47. Lin Y, Ghijsen MT, Gao H, Liu N, Nalcioglu O, Gulsen G. PMID: 21753235; PMCID: PMC3961472.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    12. Simultaneous in vivo dynamic contrast-enhanced magnetic resonance and scintigraphic imaging. Phys Med Biol. 2011 Feb 21; 56(4):N63-9. Hamamura MJ, Roeck WW, Ha S, Hugg J, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 21258141.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    13. MR-based keyhole SPECT for small animal imaging. Phys Med Biol. 2011 Feb 07; 56(3):685-702. Lee KS, Roeck WW, Gullberg GT, Nalcioglu O. PMID: 21220840; PMCID: PMC3074940.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    14. A new bias field correction method combining N3 and FCM for improved segmentation of breast density on MRI. Med Phys. 2011 Jan; 38(1):5-14. Lin M, Chan S, Chen JH, Chang D, Nie K, Chen ST, Lin CJ, Shih TC, Nalcioglu O, Su MY. PMID: 21361169; PMCID: PMC3017578.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    15. Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS. NMR Biomed. 2011 Apr; 24(3):316-24. Chen JH, Mehta RS, Baek HM, Nie K, Liu H, Lin MQ, Yu HJ, Nalcioglu O, Su MY. PMID: 20862660; PMCID: PMC3075960.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    16. Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? J Oncol. 2010; 2010. Chan S, Chen JH, Agrawal G, Lin M, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. PMID: 20885929; PMCID: PMC2946595.
      View in: PubMed   Mentions: 12  
    17. Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study. Magn Reson Imaging. 2011 Jan; 29(1):91-8. Chen JH, Chang YC, Chang D, Wang YT, Nie K, Chang RF, Nalcioglu O, Huang CS, Su MY. PMID: 20832226; PMCID: PMC3005955.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    18. Computational simulation of breast compression based on segmented breast and fibroglandular tissues on magnetic resonance images. Phys Med Biol. 2010 Jul 21; 55(14):4153-68. Shih TC, Chen JH, Liu D, Nie K, Sun L, Lin M, Chang D, Nalcioglu O, Su MY. PMID: 20601773; PMCID: PMC2993491.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. Quantitative fluorescence tomography using a trimodality system: in vivo validation. J Biomed Opt. 2010 Jul-Aug; 15(4):040503. Lin Y, Barber WC, Iwanczyk JS, Roeck WW, Nalcioglu O, Gulsen G. PMID: 20799770; PMCID: PMC2937044.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    20. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci. 2010 Jun 02; 30(22):7484-94. Dubé CM, Ravizza T, Hamamura M, Zha Q, Keebaugh A, Fok K, Andres AL, Nalcioglu O, Obenaus A, Vezzani A, Baram TZ. PMID: 20519523; PMCID: PMC2906240.
      View in: PubMed   Mentions: 117     Fields:    Translation:Animals
    21. Age- and race-dependence of the fibroglandular breast density analyzed on 3D MRI. Med Phys. 2010 Jun; 37(6):2770-6. Nie K, Su MY, Chau MK, Chan S, Nguyen H, Tseng T, Huang Y, McLaren CE, Nalcioglu O, Chen JH. PMID: 20632587; PMCID: PMC2885945.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    22. A PIN diode controlled dual-tuned MRI RF coil and phased array for multi nuclear imaging. Phys Med Biol. 2010 May 07; 55(9):2589-600. Ha S, Hamamura MJ, Nalcioglu O, Muftuler LT. PMID: 20393229.
      View in: PubMed   Mentions: 19     Fields:    
    23. Quantitative fluorescence tomography using a combined tri-modality FT/DOT/XCT system. Opt Express. 2010 Apr 12; 18(8):7835-50. Lin Y, Barber WC, Iwanczyk JS, Roeck W, Nalcioglu O, Gulsen G. PMID: 20588625; PMCID: PMC2898749.
      View in: PubMed   Mentions: 30     Fields:    
    24. Development of a new RF coil and gamma-ray radiation shielding assembly for improved MR image quality in SPECT/MRI. Phys Med Biol. 2010 May 07; 55(9):2495-504. Ha S, Hamamura MJ, Roeck WW, Muftuler LT, Nalcioglu O. PMID: 20371909.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    25. Decrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluation. Radiology. 2010 Apr; 255(1):44-52. Chen JH, Nie K, Bahri S, Hsu CC, Hsu FT, Shih HN, Lin M, Nalcioglu O, Su MY. PMID: 20308443; PMCID: PMC2843830.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    26. Magnetic resonance imaging evaluation of noninflammatory breast cancer with skin involvement after neoadjuvant chemotherapy. Ann Surg Oncol. 2010 Jul; 17(7):1964-5. Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 20180030; PMCID: PMC2889290.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    27. Development of an MR-compatible SPECT system (MRSPECT) for simultaneous data acquisition. Phys Med Biol. 2010 Mar 21; 55(6):1563-75. Hamamura MJ, Ha S, Roeck WW, Muftuler LT, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 20164533.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    28. Foreword. Technol Cancer Res Treat. 2010 Feb; 9(1):1-4. Nalcioglu O, Su MY. PMID: 20082525; PMCID: PMC4232204.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    29. Dual-contrast dynamic MRI-DOT for small animal imaging. Technol Cancer Res Treat. 2010 Feb; 9(1):61-70. Thayer D, Unlu MB, Lin Y, Yan K, Nalcioglu O, Gulsen G. PMID: 20082531; PMCID: PMC3961473.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    30. Combined fluorescence and X-Ray tomography for quantitative in vivo detection of fluorophore. Technol Cancer Res Treat. 2010 Feb; 9(1):45-52. Barber WC, Lin Y, Nalcioglu O, Iwanczyk JS, Hartsough NE, Gulsen G. PMID: 20082529; PMCID: PMC2877036.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Initial Investigation of preclinical integrated SPECT and MR imaging. Technol Cancer Res Treat. 2010 Feb; 9(1):21-8. Hamamura MJ, Ha S, Roeck WW, Wagenaar DJ, Meier D, Patt BE, Nalcioglu O. PMID: 20082527; PMCID: PMC4235993.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    32. Quantitative analysis of breast parenchymal patterns using 3D fibroglandular tissues segmented based on MRI. Med Phys. 2010 Jan; 37(1):217-26. Nie K, Chang D, Chen JH, Hsu CC, Nalcioglu O, Su MY. PMID: 20175484; PMCID: PMC2801737.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    33. Impact of skin removal on quantitative measurement of breast density using MRI. Med Phys. 2010 Jan; 37(1):227-33. Nie K, Chang D, Chen JH, Shih TC, Hsu CC, Nalcioglu O, Su MY. PMID: 20175485; PMCID: PMC2801738.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    34. Can proton MRS provide useful information for characterizing estrogen receptor status in breast cancer? Ann Oncol. 2010 Mar; 21(3):663-665. Baek HM, Chen JH, Nalcioglu O, Su MY. PMID: 19951954; PMCID: PMC2826101.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Algorithm-based method for detection of blood vessels in breast MRI for development of computer-aided diagnosis. J Magn Reson Imaging. 2009 Oct; 30(4):817-24. Lin M, Chen JH, Nie K, Chang D, Nalcioglu O, Su MY. PMID: 19787727; PMCID: PMC2789993.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    36. Selection of diagnostic features on breast MRI to differentiate between malignant and benign lesions using computer-aided diagnosis: differences in lesions presenting as mass and non-mass-like enhancement. Eur Radiol. 2010 Apr; 20(4):771-81. Newell D, Nie K, Chen JH, Hsu CC, Yu HJ, Nalcioglu O, Su MY. PMID: 19789878; PMCID: PMC2835636.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    37. Comparison of breast density in the contralateral normal breast of patients with invasive and in situ breast cancer measured on MRI. Ann Oncol. 2009 Aug; 20(8):1449-50. Chen JH, Chang D, Nie K, Hsu FT, Shih HN, Hsu CC, Nalcioglu O, Su MY. PMID: 19654205; PMCID: PMC2733064.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI? Ann Oncol. 2009 Aug; 20(8):1447-9. Chen JH, Hsu FT, Shih HN, Hsu CC, Chang D, Nie K, Nalcioglu O, Su MY. PMID: 19654204; PMCID: PMC2720819.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. A variable torque motor compatible with magnetic resonance imaging. Rev Sci Instrum. 2009 Apr; 80(4):046108. Roeck WW, Ha SH, Farmaka S, Nalcioglu O. PMID: 19405704.
      View in: PubMed   Mentions: 1     Fields:    
    40. Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon. Cancer. 2009 Apr 01; 115(7):1363-80. Agrawal G, Su MY, Nalcioglu O, Feig SA, Chen JH. PMID: 19197974; PMCID: PMC2748779.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    41. Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol. 2009 Jun; 16(6):1619-28. Bahri S, Chen JH, Mehta RS, Carpenter PM, Nie K, Kwon SY, Yu HJ, Nalcioglu O, Su MY. PMID: 19333654; PMCID: PMC2786305.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    42. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology. 2009 Jun; 251(3):653-62. Baek HM, Chen JH, Nie K, Yu HJ, Bahri S, Mehta RS, Nalcioglu O, Su MY. PMID: 19276320; PMCID: PMC2687529.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    43. Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer. Ann Surg. 2009 Mar; 249(3):448-54. Chen JH, Feig BA, Hsiang DJ, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY. PMID: 19247033; PMCID: PMC2789298.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    44. Quantitative fluorescence tomography with functional and structural a priori information. Appl Opt. 2009 Mar 01; 48(7):1328-36. Lin Y, Yan H, Nalcioglu O, Gulsen G. PMID: 19252634; PMCID: PMC2737514.
      View in: PubMed   Mentions: 28     Fields:    
    45. Quantitative analysis of lesion morphology and texture features for diagnostic prediction in breast MRI. Acad Radiol. 2008 Dec; 15(12):1513-25. Nie K, Chen JH, Yu HJ, Chu Y, Nalcioglu O, Su MY. PMID: 19000868; PMCID: PMC2791407.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    46. Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. Med Phys. 2008 Dec; 35(12):5253-62. Nie K, Chen JH, Chan S, Chau MK, Yu HJ, Bahri S, Tseng T, Nalcioglu O, Su MY. PMID: 19175084; PMCID: PMC2673600.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    47. Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging. 2008 Dec; 28(6):1499-505. Chen JH, Nalcioglu O, Su MY. PMID: 19025938; PMCID: PMC2597344.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    48. Simultaneous in vivo dynamic magnetic resonance-diffuse optical tomography for small animal imaging. J Biomed Opt. 2008 Nov-Dec; 13(6):060501. Unlu MB, Lin Y, Birgul O, Nalcioglu O, Gulsen G. PMID: 19123642; PMCID: PMC2943837.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    49. Cognitive dysfunction after experimental febrile seizures. Exp Neurol. 2009 Jan; 215(1):167-77. Dubé CM, Zhou JL, Hamamura M, Zhao Q, Ring A, Abrahams J, McIntyre K, Nalcioglu O, Shatskih T, Baram TZ, Holmes GL. PMID: 19000675; PMCID: PMC2649663.
      View in: PubMed   Mentions: 57     Fields:    Translation:AnimalsCells
    50. Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response? Ann Surg Oncol. 2008 Dec; 15(12):3609-13. Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 18807091; PMCID: PMC2613188.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Choline as a biomarker for cell proliferation: do the results from proton MR spectroscopy show difference between HER2/neu positive and negative breast cancers? Int J Cancer. 2008 Sep 01; 123(5):1219-21. Baek HM, Chen JH, Nalcioglu O, Su MY. PMID: 18546272; PMCID: PMC2613431.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    52. The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol. 2008 Jul; 82(14):7078-88. Lundberg P, Ramakrishna C, Brown J, Tyszka JM, Hamamura M, Hinton DR, Kovats S, Nalcioglu O, Weinberg K, Openshaw H, Cantin EM. PMID: 18480436; PMCID: PMC2446972.
      View in: PubMed   Mentions: 75     Fields:    Translation:AnimalsCells
    53. Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging. 2008 May; 27(5):1114-21. Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY. PMID: 18425841; PMCID: PMC2613433.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    54. Magnetic resonance imaging features of fibrocystic change of the breast. Magn Reson Imaging. 2008 Nov; 26(9):1207-14. Chen JH, Liu H, Baek HM, Nalcioglu O, Su MY. PMID: 18436406; PMCID: PMC2613187.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    55. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging. 2008 Apr; 27(4):825-33. Chen JH, Baek HM, Nalcioglu O, Su MY. PMID: 18383260; PMCID: PMC2613434.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    56. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter? Ann Oncol. 2008 May; 19(5):1024-6. Chen JH, Nalcioglu O, Su MY. PMID: 18375524; PMCID: PMC2613432.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol. 2008 May; 19(5):1022-4. Baek HM, Chen JH, Nalcioglu O, Su MY. PMID: 18372283; PMCID: PMC2613189.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    58. Can dynamic contrast-enhanced MRI (DCE-MRI) predict tumor recurrence and lymph node status in patients with breast cancer? Ann Oncol. 2008 Apr; 19(4):822-4. Bahri S, Chen JH, Yu HJ, Kuzucan A, Nalcioglu O, Su MY. PMID: 18325916; PMCID: PMC2613186.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer. 2008 Jan 01; 112(1):17-26. Chen JH, Feig B, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. PMID: 18000804.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCTClinical Trials
    60. Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy. J Clin Oncol. 2007 Dec 10; 25(35):5667-9. Chen JH, Mehta RS, Carpenter PM, Nalcioglu O, Su MY. PMID: 18065744.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging. 2008 May; 26(4):523-31. Baek HM, Yu HJ, Chen JH, Nalcioglu O, Su MY. PMID: 18060716; PMCID: PMC2653063.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    62. Triple-negative breast cancer: MRI features in 29 patients. Ann Oncol. 2007 Dec; 18(12):2042-3. Chen JH, Agrawal G, Feig B, Baek HM, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. PMID: 18029970.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    63. Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers. Ann Surg Oncol. 2008 Mar; 15(3):941-2. Chen JH, Agrawal G, Carpenter P, Mehta RS, Nalcioglu O, Su MY. PMID: 18004624.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. MRI features of breast cancer: a correlation study with HER-2 receptor. Ann Oncol. 2007 Nov; 18(11):1903-4. Agrawal G, Chen JH, Baek HM, Hsiang D, Mehta RS, Nalcioglu O, Su MY. PMID: 17993631.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    65. Fluorescence diffuse optical tomography with functional and anatomical a priori information: feasibility study. Phys Med Biol. 2007 Sep 21; 52(18):5569-85. Lin Y, Gao H, Nalcioglu O, Gulsen G. PMID: 17804882.
      View in: PubMed   Mentions: 27     Fields:    
    66. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging. 2007 Sep; 26(3):615-23. Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. PMID: 17729334.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    67. In vivo MRI volumetric measurement of prostate regression and growth in mice. BMC Urol. 2007 Jul 24; 7:12. Nastiuk KL, Liu H, Hamamura M, Muftuler LT, Nalcioglu O, Krolewski JJ. PMID: 17650332; PMCID: PMC1945027.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    68. Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol. 2007 Jun 20; 25(18):2618-20. Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O, Su MY. PMID: 17577043.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    69. Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma. 2007 Apr; 24(4):674-89. Nishi RA, Liu H, Chu Y, Hamamura M, Su MY, Nalcioglu O, Anderson AJ. PMID: 17439350.
      View in: PubMed   Mentions: 43     Fields:    Translation:Animals
    70. An optimization method for designing SENSE imaging RF coil arrays. J Magn Reson. 2007 Jun; 186(2):273-81. Chen G, Muftuler LT, Ha SH, Nalcioglu O. PMID: 17428711.
      View in: PubMed   Mentions: 2     Fields:    
    71. An inverse method to design RF coil arrays optimized for SENSE imaging. Phys Med Biol. 2006 Dec 21; 51(24):6457-69. Muftuler LT, Chen G, Nalcioglu O. PMID: 17148829.
      View in: PubMed   Mentions: 4     Fields:    
    72. Contrast and spatial resolution in MREIT using low amplitude current. Phys Med Biol. 2006 Oct 07; 51(19):5035-49. Birgul O, Hamamura MJ, Muftuler LT, Nalcioglu O. PMID: 16985286.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    73. Diffuse optical tomographic reconstruction using multifrequency data. J Biomed Opt. 2006 Sep-Oct; 11(5):054008. Burcin Unlu M, Birgul O, Shafiiha R, Gulsen G, Nalcioglu O. PMID: 17092157.
      View in: PubMed   Mentions: 9     Fields:    
    74. Resolution improvement in positron emission tomography using anatomical Magnetic Resonance Imaging. Technol Cancer Res Treat. 2006 Aug; 5(4):311-7. Chu Y, Su MY, Mandelkern M, Nalcioglu O. PMID: 16866561.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    75. Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat. 2006 Aug; 5(4):351-63. Gulsen G, Birgul O, Unlu MB, Shafiiha R, Nalcioglu O. PMID: 16866566.
      View in: PubMed   Mentions: 28     Fields:    Translation:Animals
    76. In vivo MRI electrical impedance tomography (MREIT) of tumors. Technol Cancer Res Treat. 2006 Aug; 5(4):381-7. Muftuler LT, Hamamura MJ, Birgul O, Nalcioglu O. PMID: 16866568.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    77. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat. 2006 Aug; 5(4):401-10. Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. PMID: 16866570.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    78. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA. 2006 May; 19(2):96-104. Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. PMID: 16779565.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    79. Measurement of ion diffusion using magnetic resonance electrical impedance tomography. Phys Med Biol. 2006 Jun 07; 51(11):2753-62. Hamamura MJ, Muftuler LT, Birgul O, Nalcioglu O. PMID: 16723764.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    80. Design and implementation of a multifrequency near-infrared diffuse optical tomography system. J Biomed Opt. 2006 Jan-Feb; 11(1):014020. Gulsen G, Xiong B, Birgul O, Nalcioglu O. PMID: 16526897.
      View in: PubMed   Mentions: 17     Fields:    
    81. Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer. Technol Cancer Res Treat. 2005 Oct; 4(5):549-58. Hsiang D, Shah N, Yu H, Su MY, Cerussi A, Butler J, Baick C, Mehta R, Nalcioglu O, Tromberg B. PMID: 16173825.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    82. Pharmacokinetic parameters analyzed from mr contrast enhancement kinetics of multiple malignant and benign breast lesions detected in the same patients. Technol Cancer Res Treat. 2005 Jun; 4(3):255-63. Su MY, Yu HJ, Carpenter PM, McLaren CE, Nalcioglu O. PMID: 15896081.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    83. Resolution and contrast in magnetic resonance electrical impedance tomography (MREIT) and its application to cancer imaging. Technol Cancer Res Treat. 2004 Dec; 3(6):599-609. Muftuler LT, Hamamura M, Birgul O, Nalcioglu O. PMID: 15560718.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    84. Serial MRI after experimental febrile seizures: altered T2 signal without neuronal death. Ann Neurol. 2004 Nov; 56(5):709-14. Dubé C, Yu H, Nalcioglu O, Baram TZ. PMID: 15389889; PMCID: PMC3084032.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    85. Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice. Am J Pathol. 2004 Aug; 165(2):449-56. Samoszuk M, Deng T, Hamamura MJ, Su MY, Asbrock N, Nalcioglu O. PMID: 15277219; PMCID: PMC1618560.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    86. Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms. Technol Cancer Res Treat. 2003 Dec; 2(6):563-9. Merritt S, Gulsen G, Chiou G, Chu Y, Deng C, Cerussi AE, Durkin AJ, Tromberg BJ, Nalcioglu O. PMID: 14640767.
      View in: PubMed   Mentions: 32     Fields:    
    87. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging. 2003 Oct; 18(4):467-77. Su MY, Cheung YC, Fruehauf JP, Yu H, Nalcioglu O, Mechetner E, Kyshtoobayeva A, Chen SC, Hsueh S, McLaren CE, Wan YL. PMID: 14508784.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    88. Inhibition of thrombosis in melanoma allografts in mice by endogenous mast cell heparin. Thromb Haemost. 2003 Aug; 90(2):351-60. Samoszuk M, Corwin M, Yu H, Wang J, Nalcioglu O, Su MY. PMID: 12888884.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    89. Coregistration of diffuse optical spectroscopy and magnetic resonance imaging in a rat tumor model. Appl Opt. 2003 Jun 01; 42(16):2951-9. Merritt S, Bevilacqua F, Durkin AJ, Cuccia DJ, Lanning R, Tromberg BJ, Gulsen G, Yu H, Wang J, Nalcioglu O. PMID: 12790444.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    90. In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration. Appl Opt. 2003 Jun 01; 42(16):2940-50. Cuccia DJ, Bevilacqua F, Durkin AJ, Merritt S, Tromberg BJ, Gulsen G, Yu H, Wang J, Nalcioglu O. PMID: 12790443.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    91. A simple simultaneous geometric and intensity correction method for echo-planar imaging by EPI-based phase modulation. IEEE Trans Med Imaging. 2003 Feb; 22(2):200-5. Chiou JY, Ahn CB, Muftuler LT, Nalcioglu O. PMID: 12715996.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    92. Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring. Technol Cancer Res Treat. 2002 Dec; 1(6):479-88. Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. PMID: 12625775.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    93. Congruent MRI and near-infrared spectroscopy for functional and structural imaging of tumors. Technol Cancer Res Treat. 2002 Dec; 1(6):497-505. Gulsen G, Yu H, Wang J, Nalcioglu O, Merritt S, Bevilacqua F, Durkin AJ, Cuccia DJ, Lanning R, Tromberg BJ. PMID: 12625777.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    94. A longitudinal study of radiation-induced changes in tumor vasculature by contrast-enhanced magnetic resonance imaging. Radiat Res. 2002 Aug; 158(2):152-8. Yu H, Su MY, Wang Z, Nalcioglu O. PMID: 12105984.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    95. A double end-cap birdcage RF coil for small animal whole body imaging. J Magn Reson. 2002 Jun; 156(2):309-12. Gulsen G, Muftuler LT, Nalcioglu O. PMID: 12165267.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    96. Assessment of protamine-induced thrombosis of tumor vessels for cancer therapy using dynamic contrast-enhanced MRI. NMR Biomed. 2002 Apr; 15(2):106-13. Su MY, Samoszuk MK, Wang J, Nalcioglu O. PMID: 11870906.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    97. Automatic tuned MRI RF coil for multinuclear imaging of small animals at 3T. J Magn Reson. 2002 Mar; 155(1):39-44. Muftuler LT, Gulsen G, Sezen KD, Nalcioglu O. PMID: 11945031.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    98. Measuring microvascular density in tumors by digital dissection. Anal Quant Cytol Histol. 2002 Feb; 24(1):15-22. Samoszuk M, Leonor L, Espinoza F, Carpenter PM, Nalcioglu O, Su MY. PMID: 11865945.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    99. Applications of dynamic contrast enhanced MRI in oncology: measurement of tumor oxygen tension. Technol Cancer Res Treat. 2002 Feb; 1(1):29-38. Wang Z, Su MY, Nalcioglu O. PMID: 12614174.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    100. FMRI study relevant to the Mozart effect: brain areas involved in spatial-temporal reasoning. Neurol Res. 2001 Oct; 23(7):683-90. Bodner M, Muftuler LT, Nalcioglu O, Shaw GL. PMID: 11680506.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    101. Effect of vasodilator hydralazine on tumor microvascular random flow and blood volume as measured by intravoxel incoherent motion (IVIM) weighted MRI in conjunction with Gd-DTPA-Albumin enhanced MRI. Magn Reson Imaging. 2001 Oct; 19(8):1063-72. Wang Z, Su MY, Najafi A, Nalcioglu O. PMID: 11711230.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    102. Selective thrombosis of tumor blood vessels in mammary adenocarcinoma implants in rats. Am J Pathol. 2001 Jul; 159(1):245-51. Samoszuk MK, Su MY, Najafi A, Nalcioglu O. PMID: 11438471; PMCID: PMC1850411.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    103. Improvement of temporal resolution in fMRI using slice phase encode reordered 3D EPI. Magn Reson Med. 2000 Sep; 44(3):485-90. Muftuler LT, Nalcioglu O. PMID: 10975903.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    104. Prediction of gene therapy-induced tumor size changes by the vascularity changes measured using dynamic contrast-enhanced MRI. Magn Reson Imaging. 2000 Apr; 18(3):311-7. Su MY, Taylor JA, Villarreal LP, Nalcioglu O. PMID: 10745141.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    105. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia. 2000 Jan-Apr; 2(1-2):152-65. Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. PMID: 10933074; PMCID: PMC1531871.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimals
    106. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents. J Magn Reson Imaging. 1999 Feb; 9(2):177-86. Su MY, Wang Z, Carpenter PM, Lao X, Mühler A, Nalcioglu O. PMID: 10077011.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    107. Investigation of longitudinal vascular changes in control and chemotherapy-treated tumors to serve as therapeutic efficacy predictors. J Magn Reson Imaging. 1999 Jan; 9(1):128-37. Su MY, Wang Z, Nalcioglu O. PMID: 10030660.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    108. Magnetic resonance imaging of anatomic and vascular characteristics in a canine model of human aging. Neurobiol Aging. 1998 Sep-Oct; 19(5):479-85. Su MY, Head E, Brooks WM, Wang Z, Muggenburg BA, Adam GE, Sutherland R, Cotman CW, Nalcioglu O. PMID: 9880050.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimals
    109. Measurement of tumor vascular volume and mean microvascular random flow velocity magnitude by dynamic Gd-DTPA-albumin enhanced and diffusion-weighted MRI. Magn Reson Med. 1998 Sep; 40(3):397-404. Wang Z, Su MY, Nalcioglu O. PMID: 9727942.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    110. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn Reson Med. 1998 Feb; 39(2):259-69. Su MY, Mühler A, Lao X, Nalcioglu O. PMID: 9469709.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimals
    111. An FEM approach for the characterization of the RF field homogeneity at high field. Magn Reson Med. 1997 Jan; 37(1):76-83. Guclu C, Kashmar G, Hacinliyan A, Nalcioglu O. PMID: 8978635.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    112. Pharmacokinetic changes induced by vasomodulators in kidneys, livers, muscles, and implanted tumors in rats as measured by dynamic Gd-DTPA-enhanced MRI. Magn Reson Med. 1996 Dec; 36(6):868-77. Su MY, Wang Z, Roth GM, Lao X, Samoszuk MK, Nalcioglu O. PMID: 8946352.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    113. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA. Magn Reson Med. 1995 Sep; 34(3):402-11. Su MY, Najafi AA, Nalcioglu O. PMID: 7500880.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    114. Homonuclear J-refocused spectral editing technique for quantification of glutamine and glutamate by 1H NMR spectroscopy. Magn Reson Med. 1995 Aug; 34(2):253-9. Lee HK, Yaman A, Nalcioglu O. PMID: 7476085.
      View in: PubMed   Mentions: 12     Fields:    
    115. Data analysis for dynamic contrast-enhanced MRI-based cerebral perfusion measurements: correcting for changing cortical CSF volumes. MAGMA. 1995 Mar; 3(1):41-8. Emerson JF, Chen PC, Shankle WR, Haier RJ, Nalcioglu O. PMID: 7600175.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    116. Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med. 1994 Dec; 32(6):714-24. Su MY, Jao JC, Nalcioglu O. PMID: 7869893.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    117. Cortical CSF volume fluctuations by MRI in brain aging, dementia and hydrocephalus. Neuroreport. 1994 Sep 08; 5(14):1699-704. Emerson JF, Chen PC, Shankle WR, Greensite FS, Foltz EL, Lott IT, Nalcioglu O. PMID: 7827311.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    118. Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down's syndrome. Neurology. 1994 Jun; 44(6):1039-45. Kesslak JP, Nagata SF, Lott I, Nalcioglu O. PMID: 8208396.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    119. Monitoring of pO2 by spin-spin relaxation rate 1/T2 of 19F in a rabbit abscess model. Artif Cells Blood Substit Immobil Biotechnol. 1994; 22(4):1449-54. Guo Q, Mattrey RF, Guclu C, Buxton RB, Nalcioglu O. PMID: 7849956.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    120. Statistical description of microcirculatory flow as measured with an MR method. J Magn Reson Imaging. 1993 Nov-Dec; 3(6):883-7. Su MY, Nalcioglu O. PMID: 8280978.
      View in: PubMed   Mentions:    Fields:    
    121. Susceptibility effects in porous media in the presence of flow. J Magn Reson Imaging. 1993 Sep-Oct; 3(5):794-9. Su MY, Nalcioglu O. PMID: 8400567.
      View in: PubMed   Mentions:    Fields:    
    122. Flow field mapping by multi-zone adiabatic passage excitation. Magn Reson Imaging. 1993; 11(8):1129-37. Vu AT, Lee HK, Moran PR, Nalcioglu O. PMID: 8271899.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    123. Reduced-bandwidth method for F-19 imaging of perflubron. J Magn Reson Imaging. 1992 Sep-Oct; 2(5):563-8. Lee HK, Nalcioglu O. PMID: 1392249.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    124. Correction of chemical-shift artifacts in multislice F-19 imaging with perfluorooctyl bromide. Magn Reson Med. 1992 Feb; 23(2):324-32. Ozdemirel B, Nalcioglu O. PMID: 1549046.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Correction of chemical-shift artifacts in 19F imaging of PFOB: a robust signed magnitude method. Magn Reson Med. 1992 Feb; 23(2):254-63. Lee HK, Nalcioglu O, Buxton RB. PMID: 1549040.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    126. Reblurred deconvolution method for chemical shift removal in F-19 (PFOB) MR imaging. J Magn Reson Imaging. 1992 Jan-Feb; 2(1):53-61. Lee HK, Nalcioglu O. PMID: 1623281.
      View in: PubMed   Mentions: 3     Fields:    
    127. Measurement of three-dimensional radiation dose distributions using MRI. Radiat Res. 1991 Oct; 128(1):1-13. Prasad PV, Nalcioglu O, Rabbani B. PMID: 1924718.
      View in: PubMed   Mentions: 2     Fields:    
    128. Correction for chemical-shift artifacts in 19F imaging of PFOB: simultaneous multislice imaging. Magn Reson Med. 1991 Sep; 21(1):21-9. Lee HK, Nalcioglu O, Buxton RB. PMID: 1943676.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    129. A modified pulse sequence for in vivo diffusion imaging with reduced motion artifacts. Magn Reson Med. 1991 Mar; 18(1):116-31. Prasad PV, Nalcioglu O. PMID: 2062224.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    130. Absolute cross-sectional area measurements in quantitative coronary arteriography by dual-energy DSA. Invest Radiol. 1991 Feb; 26(2):119-27. Molloi SY, Ersahin A, Roeck WW, Nalcioglu O. PMID: 2055711.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    131. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 1991 Jan; 41(1):51-4. Kesslak JP, Nalcioglu O, Cotman CW. PMID: 1985296.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    132. Cartesian echo planar hybrid scanning with two to eight echoes. IEEE Trans Med Imaging. 1991; 10(1):1-10. Kashmar G, Nalcioglu O. PMID: 18222795.
      View in: PubMed   Mentions:    Fields:    
    133. Spatially resolved flow velocity measurements and projection angiography by adiabatic passage. Magn Reson Imaging. 1991; 9(1):115-27. Lee HK, Nalcioglu O, Moran PR. PMID: 2056849.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    134. NMR angiography with enhanced quasi-half-echo scanning. Magn Reson Imaging. 1991; 9(2):129-39. Guo Q, Kashmar G, Nalcioglu O. PMID: 2034045.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    135. Projection images of the position-velocity joint spin density distribution. Magn Reson Med. 1990 Jul; 15(1):112-20. Xiang QS, Nalcioglu O. PMID: 2374491.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    136. Investigation of blood flow dynamics by NMR angiography. Magn Reson Imaging. 1990; 8(2):167-72. Guo Q, Friloux L, Nalcioglu O. PMID: 2338897.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    137. Differential flow imaging by NMR. Magn Reson Med. 1989 Oct; 12(1):14-24. Xiang QS, Nalcioglu O. PMID: 2607957.
      View in: PubMed   Mentions:    Fields:    
    138. Correlation of minimum coronary lumen diameter with left ventricular functional impairment induced by atrial pacing. Am J Cardiol. 1988 Apr 01; 61(10):697-703. Tobis J, Sato D, Nalcioglu O, Johnston WD, Mallery J, See J, Qu L, Reese T, Paynter J, Montelli S, et al. PMID: 3354432.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. Measurement of mean and variance of velocity fields within each voxel by NMR imaging. IEEE Trans Med Imaging. 1988; 7(4):364-7. Xiang QS, Nalcioglu O. PMID: 18230490.
      View in: PubMed   Mentions:    Fields:    
    140. Methods and algorithms for Fourier-transform nuclear magnetic resonance tomography. J Opt Soc Am A. 1987 May; 4(5):923-32. Cho ZH, Nalcioglu O, Park HW. PMID: 3598744.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    141. Measurement of bulk and random directional velocity fields by NMR imaging. IEEE Trans Med Imaging. 1987; 6(4):356-9. Nalcioglu O, Cho ZH. PMID: 18244045.
      View in: PubMed   Mentions: 1     Fields:    
    142. Videodensitometric determination of minimum coronary artery luminal diameter before and after angioplasty. Am J Cardiol. 1987 Jan 01; 59(1):38-44. Tobis J, Nalcioglu O, Johnston WD, Qu L, Reese T, Sato D, Roeck W, Montelli S, Henry WL. PMID: 2949580.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    143. The effects of random directional distributed flow in nuclear magnetic resonance imaging. Med Phys. 1987 Jan-Feb; 14(1):43-8. Ahn CB, Lee SY, Nalcioglu O, Cho ZH. PMID: 3561335.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    144. A fonnalism for generating multiparametric encoding gradients in NMR tomography. IEEE Trans Med Imaging. 1987; 6(1):14-20. Xiang QS, Nalcioglu O. PMID: 18230422.
      View in: PubMed   Mentions:    Fields:    
    145. An improved nuclear magnetic resonance diffusion coefficient imaging method using an optimized pulse sequence. Med Phys. 1986 Nov-Dec; 13(6):789-93. Ahn CB, Lee SY, Nalcioglu O, Cho ZH. PMID: 3796474.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    146. Digital angiography: the implementation of computer technology for cardiovascular imaging. Prog Cardiovasc Dis. 1985 Nov-Dec; 28(3):195-212. Tobis J, Nalcioglu O, Henry W. PMID: 3903864.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    147. Determination of the optimal timing for performing digital ventriculography during atrial pacing stress tests in coronary heart disease. Am J Cardiol. 1985 Sep 01; 56(7):426-33. Tobis J, Iseri L, Johnston WD, Nalcioglu O, De Boer C, Shah A, Paynter J, Henry WL. PMID: 3898797.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    148. Digital coronary roadmapping as an aid for performing coronary angioplasty. Am J Cardiol. 1985 Aug 01; 56(4):237-41. Tobis J, Johnston WD, Montelli S, Henderson E, Roeck W, Bauer B, Nalcioglu O, Henry W. PMID: 3161319.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    149. Chemical-shift artifact correction scheme using echo-time encoding technique. Magn Reson Med. 1985 Jun; 2(3):253-61. Cho ZH, Nalcioglu O, Park HW, Ra JB, Hilal SK. PMID: 3831694.
      View in: PubMed   Mentions: 2     Fields:    
    150. Removal of image intensifier veiling glare by mathematical deconvolution techniques. Med Phys. 1985 May-Jun; 12(3):281-8. Seibert JA, Nalcioglu O, Roeck W. PMID: 4010632.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    151. Constrained iterative reconstruction by the conjugate gradient method. IEEE Trans Med Imaging. 1985; 4(2):65-71. Kawata S, Nalcioglu O. PMID: 18243953.
      View in: PubMed   Mentions: 5     Fields:    
    152. On the relationship of image intensifier contrast ratios measured by two techniques. Phys Med Biol. 1984 Oct; 29(10):1231-6. Nalcioglu O, Roeck WW, Lando AV, Seibert JA. PMID: 6494249.
      View in: PubMed   Mentions:    Fields:    
    153. Detection and quantitation of coronary artery stenoses from digital subtraction angiograms compared with 35-millimeter film cineangiograms. Am J Cardiol. 1984 Sep 01; 54(6):489-96. Tobis J, Nalcioglu O, Iseri L, Johnston WD, Roeck W, Castleman E, Bauer B, Montelli S, Henry WL. PMID: 6383001.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    154. Limits to signal-to-noise improvement by FID averaging in NMR imaging. Phys Med Biol. 1984 Aug; 29(8):969-78. Nalcioglu O, Cho ZH. PMID: 6483968.
      View in: PubMed   Mentions: 3     Fields:    
    155. Characterization of the veiling glare PSF in x-ray image intensified fluoroscopy. Med Phys. 1984 Mar-Apr; 11(2):172-9. Seibert JA, Nalcioglu O, Roeck WW. PMID: 6727792.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    156. Measurement of left ventricular ejection fraction by videodensitometric analysis of digital subtraction angiograms. Am J Cardiol. 1983 Oct 01; 52(7):871-5. Tobis J, Nalcioglu O, Seibert A, Johnston WD, Henry WL. PMID: 6353899.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    157. Digital subtraction angiography. Chest. 1983 Jul; 84(1):68-75. Tobis JM, Nalcioglu O, Henry WL. PMID: 6345103.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    158. Correlation of 10-milliliter digital subtraction ventriculograms compared with standard cineangiograms. Am Heart J. 1983 Jun; 105(6):946-52. Tobis JM, Nalcioglu O, Johnston WD, Seibert A, Roeck W, Iseri LT, Elkayam U, Henry WL. PMID: 6344605.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    159. Digital angiography in assessment of ventricular function and wall motion during pacing in patients with coronary artery disease. Am J Cardiol. 1983 Mar 01; 51(5):668-75. Tobis J, Nalcioglu O, Johnston WD, Seibert A, Iseri LT, Roeck W, Henry WL. PMID: 6338687.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    160. Normalization (division) versus subtraction of digitized images. Med Phys. 1983 Jan-Feb; 10(1):25-8. Baily NA, Rimkus D, Nalcioglu O. PMID: 6341800.
      View in: PubMed   Mentions: 1     Fields:    
    161. Undersampling Errors in Region-of-Interest Tomography. IEEE Trans Med Imaging. 1982; 1(3):168-73. Sankar PV, Nalcioglu O, Sklansky J. PMID: 18238271.
      View in: PubMed   Mentions: 2     Fields:    
    162. A method for dose determination in computerized tomography. Health Phys. 1979 Oct; 37(4):543-8. Yalcintas MG, Nalcioglu O. PMID: 536216.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    163. Post-reconstruction method for beam hardening in computerised tomography. Phys Med Biol. 1979 Mar; 24(2):330-40. Nalcioglu O, Lou RY. PMID: 450974.
      View in: PubMed   Mentions: 7     Fields:    
    Orhan's Networks
    Concepts (479)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (23)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California